Solid Biosciences Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Solid Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q2 2024.
  • Solid Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.09M, a 7.61% increase year-over-year.
  • Solid Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.27M, a 1.3% increase year-over-year.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.63M, a 1.17% increase from 2022.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.54M, a 43.6% decline from 2021.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.4M, a 15% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.27M $2.09M +$148K +7.61% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $7.12M $1.61M -$507K -23.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $7.63M $1.94M +$351K +22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $7.27M $1.63M +$101K +6.63% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $7.17M $1.94M +$130K +7.17% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $7.04M $2.12M -$494K -18.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $7.54M $1.59M -$1.83M -53.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $9.37M $1.52M -$1.89M -55.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $11.3M $1.81M -$1.82M -50.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $13.1M $2.61M -$295K -10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $13.4M $3.42M +$897K +35.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $12.5M $3.42M +$652K +23.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $11.8M $3.64M +$392K +12.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $11.4M $2.91M -$197K -6.35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $11.6M $2.52M -$886K -26% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $12.5M $2.76M -$628K -18.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $13.1M $3.24M -$668K -17.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $13.8M $3.1M -$396K -11.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $14.2M $3.4M +$1.37M +67.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $12.8M $3.39M +$1.6M +88.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $11.2M $3.91M +$2.6M +199% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $8.64M $3.5M +$2.68M +327% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $5.96M $2.03M +$1.21M +147% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $4.75M $1.8M +$1.01M +127% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $3.74M $1.31M +$822K +169% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $2.92M $819K -$2.41M -74.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $5.33M $823K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $790K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $487K Mar 30, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $3.23M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.